HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasmapheresis as an adjunct to management of Rh isoimmunization.

Abstract
Plasmapheresis as therapy for Rh isoimmunization has gained recent attention in Great Britain; however, this technique has not been widely accepted in the United States. At Wilford Hall USAF Medical Center, separator was beneficial in the management of a patient with Rh isoimmunization. A decrease in the delta optical density (OD) 450 followed the onset of plasmapheresis by 3 and 4 weeks and a correlation between the plasma anti-D concentration and the severity of the delta OD 450 was demonstrated.
AuthorsJ C Hauth, A L Brekken, W Pollack
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 57 Issue 1 Pg. 132-5 (Jan 1981) ISSN: 0029-7844 [Print] United States
PMID7192839 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Erythroblastosis, Fetal (therapy)
  • Female
  • Humans
  • Plasmapheresis
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: